Cargando…
The inexorable increase of biologic exposure in paediatric inflammatory bowel disease: a Scottish, population‐based, longitudinal study
BACKGROUND: The use of biologics in paediatric‐onset inflammatory bowel disease (PIBD) is rapidly changing. AIMS: To identify the incidence and prevalence of biologic use within Scottish PIBD services, and to describe patient demographics and outcomes for those patients who required escalation of th...
Autores principales: | Burgess, Christopher J., Jackson, Rebecca, Chalmers, Iain, Russell, Richard K., Hansen, Richard, Scott, Gregor, Henderson, Paul, Wilson, David C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828169/ https://www.ncbi.nlm.nih.gov/pubmed/36196524 http://dx.doi.org/10.1111/apt.17217 |
Ejemplares similares
-
Antidepressant medication use in Inflammatory Bowel Disease: a nationally representative population‐based study
por: Jayasooriya, Nishani, et al.
Publicado: (2022) -
Risk of dementia in patients with inflammatory bowel disease: a Danish population‐based study
por: Rønnow Sand, Jakob, et al.
Publicado: (2022) -
Children included in randomised controlled trials of biologics in inflammatory bowel diseases do not represent the real‐world patient mix
por: Atia, Ohad, et al.
Publicado: (2022) -
Mendelian Disease Associations Reveal Novel Insights into Inflammatory Bowel Disease
por: Han, Lichy, et al.
Publicado: (2018) -
A Mobile Infliximab Dosing Calculator for Therapy Optimization in
Inflammatory Bowel Disease
por: Piester, Travis, et al.
Publicado: (2018)